| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000006543 |
| Receipt No. | R000007754 |
| Official scientific title of the study | Efficacy and safety of Fondaparinux for prevention of venous thromboembolism (VTE) after abdominal surgery |
| Date of disclosure of the study information | 2013/12/31 |
| Last modified on | 2016/10/06 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Efficacy and safety of Fondaparinux for prevention of venous thromboembolism (VTE) after abdominal surgery | |
| Title of the study (Brief title) | Efficacy and safety of Fondaparinux for prevention of venous thromboembolism (VTE) after abdominal surgery | |
| Region |
|
|
| Condition | ||
| Condition | Colorectal cancer patients performed laparoscopic surgery at high risk of VTE | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Asses the incidence of symptomatic/ asymptomatic DVT and symptomatic PTE |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Incidence of symptomatic/ asymptomatic DVT and symptomatic PTE |
| Key secondary outcomes | Incidence of major bleeding |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Colorectal cancer patients performed laparoscopic surgery with VTE risk factor listed Japanese VTE prevention guideline
2. Written informed consent. |
|||
| Key exclusion criteria | 1. Patient who meet contraindication or precaution in package insert of anticoagulants such as Fondaparinux, UFH, LMWH, and Danaparoid
2. Patient who have experience of lower limb orthopedic surgery, abdominal surgery, cardiovascular surgery within 3 month of enrollment 3. Patient who receive contra indicated concomitant drug within 1 week after Fondaparinux administration. 4. VTE patient diagnosed before surgery 5. Patient whose D-dimer above 1 micro gram before surgery 6. Patient who have history of arterial thromboembolism 7. Drug addiction or alcohol abuse. 8. Patient who scheduled other surgery during the study 9. Pregnant women or women who have possibility of pregnancy. 10. Patient who judged inadequate to join the study by the doctor in charge. |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Katsuji Tokuhara |
| Organization | Kansai Medical University Hirakata hospital |
| Division name | Department of Surgery |
| Address | 2-3-1, Shinmachi, Hirakata, Osaka 573-1191, Japan |
| TEL | 06-6992-1001 |
| tokuhark@takii.kmu.ac.jp | |
| Public contact | |
| Name of contact person | Katsuji Tokuhara |
| Organization | Kansai Medical University Hirakata hospital |
| Division name | Department of Surgery |
| Address | 2-3-1, Shinmachi, Hirakata, Osaka 573-1191, Japan |
| TEL | 072-804-0101 |
| Homepage URL | |
| tokuhark@hirakata.kmu.ac.jp | |
| Sponsor | |
| Institute | Kansai Medical University Hirakata hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Before this study starts, there are no data. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007754 |